Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistance.
Vikova V. et al. pp.540
http://www.occitanie-invest.com/diag2tec-sattaque-myelome-multiple/
